Cargando…

Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model

BACKGROUND: US FDA draft guidance includes pathogen reduction (PR) or secondary rapid bacterial testing (RT) in its recommendations for mitigating risk of platelet component (PC) bacterial contamination. An interactive budget impact model was created for hospitals to use when considering these techn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prioli, Katherine M., Karp, Julie Katz, Lyons, Nina M., Chrebtow, Vera, Herman, Jay H., Pizzi, Laura T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244623/ https://www.ncbi.nlm.nih.gov/pubmed/30062464 http://dx.doi.org/10.1007/s40258-018-0409-3

Ejemplares similares

Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
por: Prioli, Katherine M., et al.
Publicado: (2022)

Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015)

The argument(s) for lowering the US minimum required content of apheresis platelet components
por: Benjamin, Richard J., et al.
Publicado: (2018)

Bacterial contamination of platelets for transfusion: strategies for prevention
por: Levy, Jerrold H., et al.
Publicado: (2018)

Platelets in defense against bacterial pathogens
por: Yeaman, Michael R.
Publicado: (2009)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US
por: Mearns, Elizabeth S, et al.
Publicado: (2017)

US physics begins to crumble under budget strain
Publicado: (2008)

TAILORED ACTIVITY PROGRAM (TAP) COSTS: OPPORTUNITIES TO STREAMLINE DELIVERY AND PURSUE REIMBURSEMENT
por: Pizzi, Laura T, et al.
Publicado: (2019)

Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis
por: Jensen, Ivar S., et al.
Publicado: (2015)

Cellular Response to Individual Components of the Platelet Concentrate
por: Sovkova, Vera, et al.
Publicado: (2021)

Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods
por: Védy, Dana, et al.
Publicado: (2009)

US public health budget cuts in the face of COVID-19
por: Devi, Sharmila
Publicado: (2020)

Ocean submesoscales as a key component of the global heat budget
por: Su, Zhan, et al.
Publicado: (2018)

Public Budgeting in Context
por: Willoughby, Katherine
Publicado: (2014)

Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia
por: Gordon, Louisa G, et al.
Publicado: (2021)

Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model
por: Bloudek, Lisa, et al.
Publicado: (2016)

US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
por: Bassali, Jan, et al.
Publicado: (2020)

Common Era sea-level budgets along the U.S. Atlantic coast
por: Walker, Jennifer S., et al.
Publicado: (2021)

Materials R&D priorities shift in US budget proposal for 2022
por: Dozier, Damon
Publicado: (2021)

Fixing US public health infrastructure for 1% of annual military budget
por: Krieger, Nancy
Publicado: (2022)

Lack of Thermogram Sharpness as Component of Thermographic Temperature Measurement Uncertainty Budget
por: Dziarski, Krzysztof, et al.
Publicado: (2021)

Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens
por: Swietnicki, Wieslaw
Publicado: (2021)

CHANGE IN DEMENTIA FAMILY CAREGIVERS’ WILLINGNESS TO PAY FOR A NONPHARMACOLOGIC INTERVENTION
por: Jutkowitz, Eric, et al.
Publicado: (2019)

Brazilian scientific funding agency budgets have not matched the country's economic growth
por: Helene, A.F., et al.
Publicado: (2013)

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States
por: Bell, Christopher E., et al.
Publicado: (2003)

Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
por: Bharmal, Murtuza, et al.
Publicado: (2019)

The Budget
Publicado: (1920)

Know thine spending enemy: it is us
por: Karp, Gregory, et al.
Publicado: (2008)

The capital budgeting decision : economic analysis and financing of investment projects /
por: Bierman, Harold
Publicado: (1975)

Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model
por: Hanmore, Emma, et al.
Publicado: (2013)

Draft Genome Sequence of Erwinia tracheiphila, an Economically Important Bacterial Pathogen of Cucurbits
por: Shapiro, Lori R., et al.
Publicado: (2015)

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
por: Ortendahl, Jesse D, et al.
Publicado: (2017)

Voting with your wallet? Municipal budget policy and election results
por: Baert, Stijn, et al.
Publicado: (2019)

Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center
por: Bonn, Jennifer, et al.
Publicado: (2023)

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis
por: Jensen, Ivar S., et al.
Publicado: (2016)

The Probing Behavior Component of Disease Transmission in Insect-Transmitted Bacterial Plant Pathogens
por: Ebert, Timothy A.
Publicado: (2019)

The economic benefits of increased sugar-free chewing gum in China: a budget impact analysis
por: Du, Shuo, et al.
Publicado: (2021)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t2b9jmbqkr0ftu5a9f10qt526b